December 1, 2007Journal of Cardiovascular Medicine
Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience
Key result
LGE CMR identifies focal myocardial enhancement in 100% of patients with specific cardiomyopathies.
- n=9
Why the study?
Can late gadolinium enhancement CMR visualize regions of abnormal myocardium in specific cardiomyopathies?
Population
9 patients with different specific cardiomyopathies referred for gadolinium CMR over 20 months
Design
Case_series
Authors
Discussion
Loading...
Member takes
Implication
May support CMR visualization of abnormalities in specific cardiomyopathies; leaves open diagnostic utility pending larger prospective studies.
Study Design
Type
Observational (n=9)
Structured PICO
Can late gadolinium enhancement CMR visualize regions of abnormal myocardium in specific cardiomyopathies?
P
Population
9 patients with different specific cardiomyopathies referred for gadolinium CMR over a 20-month period.
E
Exposure
Late gadolinium enhancement cardiovascular magnetic resonance (CMR)
O
Outcome
Visualization and distribution pattern of myocardial late gadolinium enhancementsurrogate
Late gadolinium enhancement CMR can identify focal myocardial abnormalities in specific cardiomyopathies, demonstrating patterns distinct from ischemic injury.
Cite This Study
Silva et al. (2007) conducted an observational in specific cardiomyopathies (n=9). Late gadolinium enhancement cardiovascular magnetic resonance was evaluated on Presence of late enhancement. Late gadolinium enhancement CMR demonstrated focal myocardial late enhancement in 100% of patients with specific cardiomyopathies, with a mean signal intensity of 390 +/- 220% versus normal regions.